BIOGRUND and Syntegon Partner to Make Your Life Easier

In many of my previous Syntegon articles, I have lamented the high cost of drug product development, with good reason. Developing an oral-solid-dose drug product is an expensive and risky endeavor, with formulation and process development being among the most significant and time consuming challenges.

It is no secret that formulation scientists face a host of hurdles when developing a formulation bound for tablet compression. First and foremost is achieving …more


Successful Versynta small batch event

Last week, Syntegon hosted the Versynta Small Batch Event, opening the virtual doors to the Crailsheim production plant for attendees from around the world. During the event, external speakers from IPS, Valicare and Ferring GmbH shared their expertise related to the growing small batch pharma field. A live, detailed demonstration of the Versynta Flexible Filling Platform (FFP) followed, highlighting the individually configurable and flexible machine for filling aseptic and high potent liquid active ingredients. The showcase concluded with …more


Take your molecule to production

Compromise no longer; Syntegon’s GKF 60 R&D capsule filler is here! The GKF 60 combines a small machine footprint with the durability, innovation and flexibility you have grown to expect from Syntegon.  When designing the GKF 60, our mission was simple, “design it to do everything.” We think you will agree that it does exactly that.

In the OSD product development world there a few hard and fast rules; plans change; timelines shrink; and API is scarce. That is where the flexibility of the GKF 60 comes in. …more


Syntegon’s Slide Gate Technology Improves Capsule Filling Performance

Although Syntegon’s tamping-style capsule filling machines have set the standard for precision and durability in capsule filling for decades, that does not mean we rest on our laurels. At Syntegon, we tirelessly pursue innovations that make our industry leading equipment even better.  One of the most important of those innovations to come out of Syntegon’s Waiblingen, Germany facility in recent years is slide gate technology for capsule fillers. …more


Syntegon’s Pilot Scale High-Shear Mixer and Fluid Bed

Developing a pharmaceutical product within a Research and Development Lab can be a very expensive and time-consuming process for OSD manufacturers. Once a stable product has been developed within the lab setting, scaling up to pilot production can prove even more daunting for scientists. Pilot-scale machines provide pharmaceutical companies the tools to better understand a manufacturing process that was successful at lab scale, while also allowing for batches at less than production scale, where design changes can still be easily executed at less cost. Syntegon offers …more


How do I get my materials into an Isolator?

Fill/finish lines surrounded by RABS and/or Isolators come with many benefits, but one of the initial challenges is determining how to transfer commodities, fluid paths, tools or drug product itself into the closed ISO 5 space. Have no fear, Syntegon’s experts are here! Join Matthias Angelmaier and Dr. Laura Moody on Wednesday, May 12th at 10am CDT for the final chapter in Syntegon’s Isolator webinar series, as they describe the various techniques used to quickly and safely move materials across barriers and into the final fill production space. Click here to register.


Next chapter in Isolator webinar series

On Wednesday, April 28th, the next chapter in Syntegon’s Isolator webinar series launches. Our experts Stefan Schuh, Dr. Laura Moody and Matthias Angelmaier will lead our free event, “How to handle complex isolator lines: Insights into the project life cycle of a liquid lyo-line”. Join them to learn more …more


Automated Capsule Product Development comes to the US at Syntegon’s Partner, Parsolex

Developing an oral solid dosage (OSD) product is not easy; timelines are long, financial risks are considerable and challenges are many. Consequently, significant incentive exists to find efficiencies and streamline the product development process wherever possible. However, one aspect of the pharma development process remains unchanged. Regulatory agencies are unwavering in their demand for evidence that your manufacturing process is stable and the design space well defined; …more


For effective moist heat terminal sterilization for large/small volume parenteral products, Syntegon delivers leading performance

Whenever feasible, regulatory agencies require injectable products to be terminally sterilized. Due to somewhat fragile molecules and compounds, this aseptic process may render the intended product to be adversely impacted and not endure the stress that moist-heat processes may subject them to. However, for those products that are more compatible to the heat and exposure, …more


Isolator webinar series continues!

You asked and Syntegon listened. Three new, free isolator-focused webinars are in the works, focused on crowdsourced topics that are important to you. Matthias Angelmaier, global product manager for barrier systems, isolator and process technology and Dr. Laura Moody, North American product manager for primary packaging, will keep the conversation going with a new variety of subjects: qualification & validation, project management of complex isolator lines and material transfer into barrier systems. On April 14th, …more


Top of page

Dear visitor,

6,100 employees, up to 150 years of experience, one thing is new: our name!
From now on we are called: Syntegon

Our website can be reached in the future at: www.syntegon.com
What is behind Syntegon? The numbers speak for themselves: www.syntegon.com/numbers

Your Syntegon Team
Close window